News from Takeda A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 10, 2014, 09:00 ET

Takeda and Zinfandel Pharmaceuticals to Present Data at Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches to Alzheimer's Disease Research and Development

 Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), will present data during...

Jun 17, 2014, 09:00 ET

Results of a New Study of Brintellix® (vortioxetine) vs. Escitalopram on Sexual Functioning in Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction

Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual...

Jun 16, 2014, 10:00 ET

ENTYVIO™ (vedolizumab) Now Available in the United States for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis and Crohn's Disease

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the...

Jun 16, 2014, 06:30 ET

New CONNECT Study Presents data on Measures of Cognitive Performance in Adult Patients Treated with Brintellix® (vortioxetine) for Major Depressive Disorder

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated...

May 22, 2014, 16:52 ET

Jury Finds for Takeda in Diabetes Drug Case

Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Bertha Triana and Delores Cipriano v. Takeda, et al., No. A680556 the...

May 20, 2014, 18:14 ET

FDA Approves Takeda's Entyvio™ (vedolizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...

May 15, 2014, 16:52 ET

Jury Finds for Takeda in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Whitlatch v. Takeda the jury found in favor of Takeda. The trial...

Apr 08, 2014, 00:51 ET

Takeda Responds to Verdict in Diabetes Drug Case

 Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al,...

Mar 27, 2014, 08:00 ET

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes:...

Mar 18, 2014, 10:47 ET

Takeda nomme Giles Platford au poste de Directeur des marchés émergents

Takeda Pharmaceuticals International GmbH (« Takeda ») a annoncé aujourd'hui la nomination de Giles Platford au poste de Directeur...

Mar 18, 2014, 05:00 ET

Takeda Appoints Giles Platford Head of Emerging Markets

Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of Commercial Operations,...

Mar 18, 2014, 05:00 ET

Takeda nomeia Giles Platford para chefia de Mercados Emergentes

A Takeda Pharmaceuticals International GmbH ("Takeda") anunciou hoje que Giles Platford foi nomeado chefe de Operações Comerciais de...

Mar 18, 2014, 05:00 ET

Takeda nombra director de mercados emergentes a Giles Platford

Takeda Pharmaceuticals International GmbH ("Takeda") anunció hoy que Giles Platford asumió la dirección de operaciones...

Jan 21, 2014, 09:00 ET

Takeda and Lundbeck Announce Brintellix® (vortioxetine) for the Treatment of Major Depressive Disorder in Adults is Now Available in Pharmacies

Takeda Pharmaceuticals U.S.A., Inc. (Takeda) and Lundbeck US jointly announced today that Brintellix (vortioxetine), for the treatment of major...

Dec 24, 2013, 10:57 ET

Takeda Announces Extension of FDA PDUFA Action Date for Vedolizumab for Ulcerative Colitis

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that...

Dec 18, 2013, 04:00 ET

Takeda Launches New Subsidiary in Israel

Demonstrates Takeda's commitment to bring new, innovative treatments to patients Takeda Pharmaceuticals International GmbH ("Takeda") today...

Dec 12, 2013, 18:01 ET

Takeda Drives Leading PAMES Study in Brazil Showing Improved Symptom Relief for People with Erosive Gastroesophageal Reflux Disease (GERD)

- First Head to Head Study Showed Tecta® As Effective for Healing and Complete Remission of Erosive GERD with Significantly Higher...

Dec 09, 2013, 20:09 ET

FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a...

Nov 14, 2013, 10:43 ET

Takeda's Deerfield Campus Among Chicago Tribune's 2013 Top 100 Workplaces

Takeda Pharmaceuticals announced today that the Chicago Tribune named Takeda's Deerfield campus among Chicago's Top 100 Workplaces in...

Nov 11, 2013, 16:30 ET

Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) and Takeda Pharmaceuticals U.S.A., Inc. (Takeda), today announced multiple Contrave®...